Dopamine agonist therapy in Parkinson¿s disease: Spanish expert consensus on its use in different clinical situations D. Santos García; J. Pagonabarraga Mora; F. Escamilla Sevilla; P.J. García Ruiz; J. Infante Ceberio; J. Kulisevsky Bojarski; G. Linazasoro Cristóbal; M.R. Luquín Piudo; J.C. Martínez Castrillo; S. Jesús Maestre; L. Vela Desojo; F.J. Campos Lucas; F. Caballero Martínez; P. Mir;

Mortality rates for Parkinson¿s disease are increasing in Spain. An age-period-cohort and joinpoint analysis of mortality rates from 1981 to 2020 C. García-Muñoz; J.C. Hernández-Rodríguez; J.J. Pereyra-Rodriguez;

The discriminative linguistic profiles of progressive supranuclear palsy and Parkinson's disease L. Busteed; A. Horta-Barba; A. Reig; C. García-Sánchez; B. Pascual-Sedano; I. Gich; P. Roy Ciffone; J. Kulisevsky; J. Pagonabarraga;